类风湿关节炎病证结合诊疗指南

2018-10-20 中华中医药学会 中医杂志.2018,59(20):1794-1800.

《类风湿关节炎病证结合诊疗指南》( 以下简称《指南》) 参照国际最新的临床实践指南制订方法,基于循证医学证据,在符合中医药理论、辨证论治原则基础上,通过对近30 年中医治疗类风湿关节炎文献的检索、梳理,结合现代研究成果,并经过中华中医药学会风湿病分会专家的广泛论证而形成。本《指南》规定了类风湿关节炎的流行病学、诊断要点、辨证论治、中成药选择、外治疗法、预防调摄、治疗推荐等,适用于类风湿关节炎病证结

中文标题:

类风湿关节炎病证结合诊疗指南

发布机构:

中华中医药学会

发布日期:

2018-10-20

简要介绍:

《类风湿关节炎病证结合诊疗指南》( 以下简称《指南》) 参照国际最新的临床实践指南制订方法,基于循证医学证据,在符合中医药理论、辨证论治原则基础上,通过对近30 年中医治疗类风湿关节炎文献的检索、梳理,结合现代研究成果,并经过中华中医药学会风湿病分会专家的广泛论证而形成。本《指南》规定了类风湿关节炎的流行病学、诊断要点、辨证论治、中成药选择、外治疗法、预防调摄、治疗推荐等,适用于类风湿关节炎病证结合诊断和治疗,旨在规范类风湿关节炎的中医临床诊断、治疗,为临床医师提供中医标准化处理策略与方法,全面提高中医风湿病临床疗效和科研水平,促进与国际学术发展接轨。 

拓展指南:类风湿性关节炎相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=类风湿关节炎病证结合诊疗指南)] GetToolGuiderByIdResponse(projectId=1, id=7d9fd1c001660656, title=类风湿关节炎病证结合诊疗指南, enTitle=, guiderFrom=中医杂志.2018,59(20):1794-1800., authorId=null, author=, summary=《类风湿关节炎病证结合诊疗指南》( 以下简称《指南》) 参照国际最新的临床实践指南制订方法,基于循证医学证据,在符合中医药理论、辨证论治原则基础上,通过对近30 年中医治疗类风湿关节炎文献的检索、梳理,结合现代研究成果,并经过中华中医药学会风湿病分会专家的广泛论证而形成。本《指南》规定了类风湿关节炎的流行病学、诊断要点、辨证论治、中成药选择、外治疗法、预防调摄、治疗推荐等,适用于类风湿关节炎病证结, cover=, journalId=null, articlesId=null, associationId=1659, associationName=中华中医药学会, associationIntro=, copyright=0, guiderPublishedTime=Sat Oct 20 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>《类风湿关节炎病证结合诊疗指南》( 以下简称《指南》) 参照国际最新的临床实践指南制订方法,基于循证医学证据,在符合中医药理论、辨证论治原则基础上,通过对近30 年中医治疗类风湿关节炎文献的检索、梳理,结合现代研究成果,并经过中华中医药学会风湿病分会专家的广泛论证而形成。本《指南》规定了类风湿关节炎的流行病学、诊断要点、辨证论治、中成药选择、外治疗法、预防调摄、治疗推荐等,适用于类风湿关节炎病证结合诊断和治疗,旨在规范类风湿关节炎的中医临床诊断、治疗,为临床医师提供中医标准化处理策略与方法,全面提高中医风湿病临床疗效和科研水平,促进与国际学术发展接轨。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>类风湿性关节炎</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=c4c9e1c00165282c" title="2018 SFR建议:类风湿性关节炎的管理(更新)" target=_blank>2018 SFR建议:类风湿性关节炎的管理(更新)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=9542f1c001615e3f" title="2018 多学科建议:类风湿性关节炎患者足部问题的诊断和治疗" target=_blank>2018 多学科建议:类风湿性关节炎患者足部问题的诊断和治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=cd2cb1c0015a14d5" title="2017 EULAR建议:支持观察研究的核心数据集和类风湿性关节炎的临床护理" target=_blank>2017 EULAR建议:支持观察研究的核心数据集和类风湿性关节炎的临床护理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=057981c00151e549" title="《2017年意大利共识指南:类风湿性关节炎患者HBV感染的管理》摘译" target=_blank>《2017年意大利共识指南:类风湿性关节炎患者HBV感染的管理》摘译</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=18ccf1c001a41e99" title="2017 意大利共识指南:类风湿性关节炎患者丙肝病毒感染的管理" target=_blank>2017 意大利共识指南:类风湿性关节炎患者丙肝病毒感染的管理</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E7%B1%BB%E9%A3%8E%E6%B9%BF%E6%80%A7%E5%85%B3%E8%8A%82%E7%82%8E" target=_blank>有关类风湿性关节炎更多指南</a></ul>, tagList=[TagDto(tagId=457, tagName=类风湿关节炎), TagDto(tagId=82629, tagName=病证结合诊疗)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9843, appHits=1080, showAppHits=8, pcHits=6793, showPcHits=3080, likes=130, shares=60, comments=3, approvalStatus=1, publishedTime=Wed Nov 07 22:12:09 CST 2018, publishedTimeString=2018-10-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Nov 07 22:12:09 CST 2018, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 09:28:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=类风湿关节炎病证结合诊疗指南)])
类风湿关节炎病证结合诊疗指南
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1192492, encodeId=f2fa1192492d9, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:05:04 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964087, encodeId=63c396408e40, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3aec5496443, createdName=ms6000000771846334, createdTime=Sun May 09 21:08:26 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901480, encodeId=51b49014800f, content=挺好的,好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/621187164de643bc9492c382e713ec39/ab493fedddf14025a0b77eeb752123cf.jpg, createdBy=57905403163, createdName=ms8000001040002112, createdTime=Mon Nov 23 16:02:10 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2022-02-11 ms3000000637975859

    非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1192492, encodeId=f2fa1192492d9, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:05:04 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964087, encodeId=63c396408e40, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3aec5496443, createdName=ms6000000771846334, createdTime=Sun May 09 21:08:26 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901480, encodeId=51b49014800f, content=挺好的,好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/621187164de643bc9492c382e713ec39/ab493fedddf14025a0b77eeb752123cf.jpg, createdBy=57905403163, createdName=ms8000001040002112, createdTime=Mon Nov 23 16:02:10 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2021-05-09 ms6000000771846334

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1192492, encodeId=f2fa1192492d9, content=非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Fri Feb 11 22:05:04 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964087, encodeId=63c396408e40, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=3aec5496443, createdName=ms6000000771846334, createdTime=Sun May 09 21:08:26 CST 2021, time=2021-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901480, encodeId=51b49014800f, content=挺好的,好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/621187164de643bc9492c382e713ec39/ab493fedddf14025a0b77eeb752123cf.jpg, createdBy=57905403163, createdName=ms8000001040002112, createdTime=Mon Nov 23 16:02:10 CST 2020, time=2020-11-23, status=1, ipAttribution=)]
    2020-11-23 ms8000001040002112

    挺好的,好好学习

    0